The pharmaceutical industry is composed of both large and small firms competing for new research, the introduction
Question:
Merck Co. and Genetics, Inc. are publicly traded large and small pharmaceutical firms, respectively. Merck Co. is considering entering into an agreement with Genetics. The agreement would require Merck to give $4M to Genetics to develop a new drug over the next two years. By doing so, Merck would obtain the right to acquire Genetics for $60 per share three years from today. If the new drug is successful, Genetics' share price is expected to double or even triple. However, if the new drug is unsuccessful. Genetics' share price is expected to decrease in value significantly. Genetics has a current stock price of $30 per share, has an expected share price volatility of 50% (including the riskiness surrounding the new-drug research), and has 1.2 million shares outstanding.
(a) Is the initial $4M that Merck is agreeing to pay Genetics justified? (Quantify your answer, and assume the risk-free rate is 6%.)
(b) Assume that Merck could also buy Genetics today for $40 per share. Compare buying Genetics today versus entering into the aforesaid agreement. Briefly discuss the advantages and disadvantages of both alternatives. If you utilize the binomial lattice approach, then only use a one-period lattice for your computations.
Fantastic news! We've Found the answer you've been seeking!
Step by Step Answer:
Related Book For
Question Posted: